CureVac, NL0015436031

CureVac, NL0015436031

16.11.2022 - 13:03:31

EQS-News: CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2022 and Provides Business Update

? ? ? ? ? (in ? millions) ? December 31, 2021(audited) ? September 30, 2022(unaudited) ? Cash and Cash Equivalents ? 811.5 ? 540.9 ? ? ? ? ? ? ? ? ? ? ? ? ? ? Three months ended September 30, ? ? ? 2021 ? 2022 ? (in ? millions) ? (unaudited) ? (unaudited) ? Revenue ? 29.3 ? 11.2 ? Cost of Sales, Operating Expenses & Other Operating Income ? -172.4 ? -63.6 ? Operating Result ? -143.1 ? -52.4 ? Financial Result ? -0.4 ? 4.7 ? Pre-Tax Loss ? -143.5 ? -47.7 ?

?

? Nine months ended September 30, ? ? ? 2021 ? 2022 ? (in ? millions) ? (unaudited) ? (unaudited) ? Revenue ? 61.8 ? 55.7 ? Cost of Sales, Operating Expenses & Other Operating Income ? -468.5 ? -183.6 ? Operating Result ? -406.7 ? -127.9 ? Financial Result ? -1.2 ? 7.5 ? Pre-Tax Loss ? -407.9 ? -120.4 ?

?

Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at www.eqs-news.com

Language: English Company: CureVac Friedrich-Miescher-Str. 15 72076 T?bingen

Germany EQS News ID: 1489427 ? End of News EQS News Service

@ dgap.de